{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T19:37:25Z","timestamp":1782761845287,"version":"3.54.5"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T00:00:00Z","timestamp":1753488000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T00:00:00Z","timestamp":1753488000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"DOI":"10.1007\/s40618-025-02648-8","type":"journal-article","created":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T05:21:48Z","timestamp":1753507308000},"page":"2427-2435","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["miR-18a-3p modulates the progression of polycystic ovary syndrome by targeting CITED2 and PI3K\/AKT signaling pathway"],"prefix":"10.1007","volume":"48","author":[{"given":"Suping","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiulian","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,26]]},"reference":[{"key":"2648_CR1","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1210\/clinem\/dgad463","volume":"108","author":"HJ Teede","year":"2023","unstructured":"Teede HJ, Tay CT, Laven JJE, Dokras A, Moran LJ, Piltonen TT, Costello MF, Boivin J, Redman LM, Boyle JA, Norman RJ, Mousa A, Joham AE (2023) Recommendations from the 2023 international Evidence-based guideline for the assessment and management of polycystic ovary syndrome. J Clin Endocrinol Metab 108:2447\u20132469. https:\/\/doi.org\/10.1210\/clinem\/dgad463","journal-title":"J Clin Endocrinol Metab"},{"key":"2648_CR2","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.fertnstert.2023.01.031","volume":"119","author":"K VanHise","year":"2023","unstructured":"VanHise K, Wang ET, Norris K, Azziz R, Pisarska MD, Chan JL (2023) Racial and ethnic disparities in polycystic ovary syndrome. Fertil Steril 119:348\u2013354. https:\/\/doi.org\/10.1016\/j.fertnstert.2023.01.031","journal-title":"Fertil Steril"},{"key":"2648_CR3","doi-asserted-by":"publisher","first-page":"1148556","DOI":"10.3389\/fendo.2023.1148556","volume":"14","author":"M Yang","year":"2023","unstructured":"Yang M, Shen X, Lu D, Peng J, Zhou S, Xu L, Zhang J (2023) Effects of vitamin D supplementation on ovulation and pregnancy in women with polycystic ovary syndrome: a systematic review and meta-analysis. Front Endocrinol (Lausanne) 14:1148556. https:\/\/doi.org\/10.3389\/fendo.2023.1148556","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2648_CR4","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.fertnstert.2018.05.004","volume":"110","author":"HJ Teede","year":"2018","unstructured":"Teede HJ, Misso ML, Costello MF, Dokras A, Laven J, Moran L, Piltonen T, Norman RJ, International PN (2018) Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Fertil Steril 110:364\u2013379. https:\/\/doi.org\/10.1016\/j.fertnstert.2018.05.004","journal-title":"Fertil Steril"},{"key":"2648_CR5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13048-022-01091-0","volume":"16","author":"H Zhao","year":"2023","unstructured":"Zhao H, Zhang J, Cheng X, Nie X, He B (2023) Insulin resistance in polycystic ovary syndrome across various tissues: an updated review of pathogenesis, evaluation, and treatment. J Ovarian Res 16:9. https:\/\/doi.org\/10.1186\/s13048-022-01091-0","journal-title":"J Ovarian Res"},{"key":"2648_CR6","doi-asserted-by":"publisher","first-page":"e20231368","DOI":"10.1590\/1806-9282.20231368","volume":"70","author":"O Tandogan","year":"2024","unstructured":"Tandogan O, Ak EY, Akdemir A, Oskay U, Callioglu N (2024) Effect of polycystic ovary syndrome on the life quality of young women. Rev Assoc Med Bras 70:e20231368. https:\/\/doi.org\/10.1590\/1806-9282.20231368","journal-title":"Rev Assoc Med Bras"},{"key":"2648_CR7","doi-asserted-by":"publisher","first-page":"21","DOI":"10.14348\/molcells.2023.2157","volume":"46","author":"H Hwang","year":"2023","unstructured":"Hwang H, Chang HR, Baek D (2023) Determinants of functional MicroRNA targeting. Mol Cells 46:21\u201332. https:\/\/doi.org\/10.14348\/molcells.2023.2157","journal-title":"Mol Cells"},{"key":"2648_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-0716-2823-2_1","volume":"2595","author":"A Vishnoi","year":"2023","unstructured":"Vishnoi A, Rani S (2023) MiRNA biogenesis and regulation of diseases: an updated overview. Methods Mol Biol 2595:1\u201312. https:\/\/doi.org\/10.1007\/978-1-0716-2823-2_1","journal-title":"Methods Mol Biol"},{"key":"2648_CR9","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.2174\/0929867329666220801161536","volume":"30","author":"M Macvanin","year":"2023","unstructured":"Macvanin M, Obradovic M, Zafirovic S, Stanimirovic J, Isenovic ER (2023) The role of MiRNAs in metabolic diseases. Curr Med Chem 30:1922\u20131944. https:\/\/doi.org\/10.2174\/0929867329666220801161536","journal-title":"Curr Med Chem"},{"key":"2648_CR10","doi-asserted-by":"publisher","first-page":"30","DOI":"10.5468\/ogs.23193","volume":"67","author":"AM Chelegahi","year":"2024","unstructured":"Chelegahi AM, Ebrahimi SO, Reiisi S, Nezamnia M (2024) A glance into the roles of MicroRNAs (exosomal and non-exosomal) in polycystic ovary syndrome. Obstet Gynecol Sci 67:30\u201348. https:\/\/doi.org\/10.5468\/ogs.23193","journal-title":"Obstet Gynecol Sci"},{"key":"2648_CR11","doi-asserted-by":"publisher","first-page":"967151","DOI":"10.3389\/fimmu.2022.967151","volume":"13","author":"W Tan","year":"2022","unstructured":"Tan W, Dai F, Yang D, Deng Z, Gu R, Zhao X, Cheng Y (2022) MiR-93-5p promotes granulosa cell apoptosis and ferroptosis by the NF-kB signaling pathway in polycystic ovary syndrome. Front Immunol 13:967151. https:\/\/doi.org\/10.3389\/fimmu.2022.967151","journal-title":"Front Immunol"},{"key":"2648_CR12","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.fertnstert.2020.08.019","volume":"115","author":"X Jiang","year":"2021","unstructured":"Jiang X, Li J, Zhang B, Hu J, Ma J, Cui L, Chen ZJ (2021) Differential expression profile of plasma Exosomal MicroRNAs in women with polycystic ovary syndrome. Fertil Steril 115:782\u2013792. https:\/\/doi.org\/10.1016\/j.fertnstert.2020.08.019","journal-title":"Fertil Steril"},{"key":"2648_CR13","doi-asserted-by":"publisher","first-page":"995","DOI":"10.7150\/ijbs.44907","volume":"17","author":"LB Wang","year":"2021","unstructured":"Wang LB, Wang DN, Wu LG, Cao J, Tian JH, Liu R, Ma R, Yu JJ, Wang J, Huang Q, Xiong WY, Zhang X (2021) Homoharringtonine inhibited breast cancer cells growth via miR-18a-3p\/AKT\/mTOR signaling pathway. Int J Biol Sci 17:995\u20131009. https:\/\/doi.org\/10.7150\/ijbs.44907","journal-title":"Int J Biol Sci"},{"key":"2648_CR14","doi-asserted-by":"publisher","first-page":"17029","DOI":"10.1038\/celldisc.2017.29","volume":"3","author":"C Rodriguez-Aguayo","year":"2017","unstructured":"Rodriguez-Aguayo C, Monroig PDC, Redis RS, Bayraktar E, Almeida MI, Ivan C, Fuentes-Mattei E, Rashed MH, Chavez-Reyes A, Ozpolat B, Mitra R, Sood AK, Calin GA, Lopez-Berestein G (2017) Regulation of hnRNPA1 by MicroRNAs controls the miR-18a-K-RAS axis in chemotherapy-resistant ovarian cancer. Cell Discov 3:17029. https:\/\/doi.org\/10.1038\/celldisc.2017.29","journal-title":"Cell Discov"},{"key":"2648_CR15","doi-asserted-by":"publisher","first-page":"155745","DOI":"10.1016\/j.cyto.2021.155745","volume":"149","author":"L Wu","year":"2022","unstructured":"Wu L, Li J, Zhao F, Xiang Y (2022) MiR-340-5p inhibits Muller cell activation and pro-inflammatory cytokine production by targeting BMP4 in experimental diabetic retinopathy. Cytokine 149:155745. https:\/\/doi.org\/10.1016\/j.cyto.2021.155745","journal-title":"Cytokine"},{"key":"2648_CR16","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2023.5252","author":"L Yang","year":"2023","unstructured":"Yang L, Cheng CF, Li ZF, Huang XJ, Cai SQ, Ye SY, Zhao LJ, Xiong Y, Chen DF, Liu HL, Ren ZX, Fang HC (2023) Berberine blocks inflammasome activation and alleviates diabetic cardiomyopathy via the miR\u201318a\u20133p\/Gsdmd pathway. Int J Mol Med 51:49. https:\/\/doi.org\/10.3892\/ijmm.2023.5252","journal-title":"Int J Mol Med"},{"key":"2648_CR17","doi-asserted-by":"publisher","first-page":"e22960","DOI":"10.1096\/fj.202201940RR","volume":"37","author":"X Jiang","year":"2023","unstructured":"Jiang X, Zhang Z, Hou M, Yang X, Cui L (2023) Plasma exosomes and contained MiRNAs affect the reproductive phenotype in polycystic ovary syndrome. FASEB J 37:e22960. https:\/\/doi.org\/10.1096\/fj.202201940RR","journal-title":"FASEB J"},{"key":"2648_CR18","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402\u2013408. https:\/\/doi.org\/10.1006\/meth.2001.1262","journal-title":"Methods"},{"key":"2648_CR19","doi-asserted-by":"publisher","first-page":"174","DOI":"10.3389\/fendo.2019.00174","volume":"10","author":"J Tu","year":"2019","unstructured":"Tu J, Cheung AH, Chan CL, Chan WY (2019) The role of MicroRNAs in ovarian granulosa cells in health and disease. Front Endocrinol (Lausanne) 10:174. https:\/\/doi.org\/10.3389\/fendo.2019.00174","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2648_CR20","doi-asserted-by":"publisher","first-page":"3635","DOI":"10.1007\/s43032-024-01523-w","volume":"31","author":"S Xiao","year":"2024","unstructured":"Xiao S, Du J, Yuan G, Luo X, Song L (2024) Granulosa Cells-Related MicroRNAs in ovarian diseases: mechanism, facts and perspectives. Reprod Sci 31:3635\u20133650. https:\/\/doi.org\/10.1007\/s43032-024-01523-w","journal-title":"Reprod Sci"},{"key":"2648_CR21","doi-asserted-by":"publisher","first-page":"111950","DOI":"10.1016\/j.mce.2023.111950","volume":"573","author":"J Chen","year":"2023","unstructured":"Chen J, Zhu Z, Xu S, Li J, Huang L, Tan W, Zhang Y, Zhao Y (2023) HDAC1 participates in polycystic ovary syndrome through histone modification by regulating H19\/miR-29a-3p\/NLRP3-mediated granulosa cell pyroptosis. Mol Cell Endocrinol 573:111950. https:\/\/doi.org\/10.1016\/j.mce.2023.111950","journal-title":"Mol Cell Endocrinol"},{"key":"2648_CR22","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/s41420-025-02331-0","volume":"11","author":"Y Lv","year":"2025","unstructured":"Lv Y, Han S, Sun F, Zhang Y, Qu X, Li H, Gu W, Xu Q, Yao S, Chen X, Jin Y (2025) Decreased miR-128-3p in serum exosomes from polycystic ovary syndrome induces ferroptosis in granulosa cells via the p38\/JNK\/SLC7A11 axis through targeting CSF1. Cell Death Discov 11:64. https:\/\/doi.org\/10.1038\/s41420-025-02331-0","journal-title":"Cell Death Discov"},{"key":"2648_CR23","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41572-024-00511-3","volume":"10","author":"E Stener-Victorin","year":"2024","unstructured":"Stener-Victorin E, Teede H, Norman RJ, Legro R, Goodarzi MO, Dokras A, Laven J, Hoeger K, Piltonen TT (2024) Polycystic ovary syndrome. Nat Rev Dis Primers 10:27. https:\/\/doi.org\/10.1038\/s41572-024-00511-3","journal-title":"Nat Rev Dis Primers"},{"key":"2648_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23020583","author":"HM Sadeghi","year":"2022","unstructured":"Sadeghi HM, Adeli I, Calina D, Docea AO, Mousavi T, Daniali M, Nikfar S, Tsatsakis A, Abdollahi M (2022) Polycystic Ovary Syndrome: A Comprehensive Review of Pathogenesis, Management, and Drug Repurposing. Int J Mol Sci 23:583. https:\/\/doi.org\/10.3390\/ijms23020583","journal-title":"Int J Mol Sci"},{"key":"2648_CR25","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1055\/s-0044-1786732","volume":"42","author":"S Yildiz","year":"2024","unstructured":"Yildiz S, Moolhuijsen LME, Visser JA (2024) The role of Anti-Mullerian hormone in ovarian function. Semin Reprod Med 42:15\u201324. https:\/\/doi.org\/10.1055\/s-0044-1786732","journal-title":"Semin Reprod Med"},{"key":"2648_CR26","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12958-022-00906-5","volume":"20","author":"P Straczynska","year":"2022","unstructured":"Straczynska P, Papis K, Morawiec E, Czerwinski M, Gajewski Z, Olejek A, Bednarska-Czerwinska A (2022) Signaling mechanisms and their regulation during in vivo or in vitro maturation of mammalian oocytes. Reprod Biol Endocrinol 20:37. https:\/\/doi.org\/10.1186\/s12958-022-00906-5","journal-title":"Reprod Biol Endocrinol"},{"key":"2648_CR27","doi-asserted-by":"publisher","first-page":"815968","DOI":"10.3389\/fendo.2022.815968","volume":"13","author":"B Liao","year":"2022","unstructured":"Liao B, Qi X, Yun C, Qiao J, Pang Y (2022) Effects of androgen Excess-Related metabolic disturbances on granulosa cell function and follicular development. Front Endocrinol (Lausanne) 13:815968. https:\/\/doi.org\/10.3389\/fendo.2022.815968","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2648_CR28","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/s13048-024-01542-w","volume":"17","author":"X Cui","year":"2024","unstructured":"Cui X, Lei X, Huang T, Mao X, Shen Z, Yang X, Peng W, Yu J, Zhang S, Huo P (2024) Follicular fluid-derived extracellular vesicles miR-34a-5p regulates granulosa cell Glycolysis in polycystic ovary syndrome by targeting LDHA. J Ovarian Res 17:223. https:\/\/doi.org\/10.1186\/s13048-024-01542-w","journal-title":"J Ovarian Res"},{"key":"2648_CR29","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1002\/em.22561","volume":"64","author":"M Ju","year":"2023","unstructured":"Ju M, Wu W, Qu J, Sun Y, Li J (2023) Downregulation of circular RNA hsa_circ_0087856 sensitizes bladder cancer cells to cisplatin through targeting miR-1184\/CITED2 signaling. Environ Mol Mutagen 64:342\u2013353. https:\/\/doi.org\/10.1002\/em.22561","journal-title":"Environ Mol Mutagen"},{"key":"2648_CR30","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s13048-023-01275-2","volume":"16","author":"J Yang","year":"2023","unstructured":"Yang J, Wang C, Zhang Y, Cheng S, Xu Y, Wang Y (2023) A novel pyroptosis-related signature for predicting prognosis and evaluating tumor immune microenvironment in ovarian cancer. J Ovarian Res 16:196. https:\/\/doi.org\/10.1186\/s13048-023-01275-2","journal-title":"J Ovarian Res"},{"key":"2648_CR31","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1038\/s41388-024-02995-5","volume":"43","author":"JM Arriaga","year":"2024","unstructured":"Arriaga JM, Ronaldson-Bouchard K, Picech F, Nunes de Almeida F, Afari S, Chhouri H, Vunjak-Novakovic G, Abate-Shen C (2024) In vivo genome-wide CRISPR screening identifies CITED2 as a driver of prostate cancer bone metastasis. Oncogene 43:1303\u20131315. https:\/\/doi.org\/10.1038\/s41388-024-02995-5","journal-title":"Oncogene"},{"key":"2648_CR32","doi-asserted-by":"publisher","first-page":"e2213622120","DOI":"10.1073\/pnas.2213622120","volume":"120","author":"M Kuna","year":"2023","unstructured":"Kuna M, Dhakal P, Iqbal K, Dominguez EM, Kent LN, Muto M, Moreno-Irusta A, Kozai K, Varberg KM, Okae H, Arima T, Sucov HM, Soares MJ (2023) CITED2 is a conserved regulator of the uterine-placental interface. Proc Natl Acad Sci U S A 120:e2213622120. https:\/\/doi.org\/10.1073\/pnas.2213622120","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2648_CR33","doi-asserted-by":"publisher","first-page":"1191759","DOI":"10.3389\/fendo.2023.1191759","volume":"14","author":"K Wang","year":"2023","unstructured":"Wang K, Li Y (2023) Signaling pathways and targeted therapeutic strategies for polycystic ovary syndrome. Front Endocrinol (Lausanne) 14:1191759. https:\/\/doi.org\/10.3389\/fendo.2023.1191759","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2648_CR34","doi-asserted-by":"publisher","first-page":"8361","DOI":"10.1007\/s11033-023-08604-0","volume":"50","author":"HS Omar","year":"2023","unstructured":"Omar HS, Ibrahim OA, Sayed MG, Faruk EM, Fouad H, Safwat M (2023) Non-coding RNA genes modulate PI3K\/AKT signaling pathway in polycystic ovary syndrome. Mol Biol Rep 50:8361\u20138372. https:\/\/doi.org\/10.1007\/s11033-023-08604-0","journal-title":"Mol Biol Rep"},{"key":"2648_CR35","doi-asserted-by":"publisher","first-page":"1091147","DOI":"10.3389\/fendo.2022.1091147","volume":"13","author":"C Tong","year":"2022","unstructured":"Tong C, Wu Y, Zhang L, Yu Y (2022) Insulin resistance, autophagy and apoptosis in patients with polycystic ovary syndrome: association with PI3K signaling pathway. Front Endocrinol (Lausanne) 13:1091147. https:\/\/doi.org\/10.3389\/fendo.2022.1091147","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2648_CR36","doi-asserted-by":"publisher","first-page":"2227280","DOI":"10.1080\/09513590.2023.2227280","volume":"39","author":"C Chen","year":"2023","unstructured":"Chen C, Jiang X, Ding C, Sun X, Wan L, Wang C (2023) Downregulated LncRNA HOTAIR ameliorates polycystic ovaries syndrome via IGF-1 mediated PI3K\/Akt pathway. Gynecol Endocrinol 39:2227280. https:\/\/doi.org\/10.1080\/09513590.2023.2227280","journal-title":"Gynecol Endocrinol"},{"key":"2648_CR37","doi-asserted-by":"publisher","first-page":"2372695","DOI":"10.1080\/14767058.2024.2372695","volume":"37","author":"J Lin","year":"2024","unstructured":"Lin J, Lin H, Li W, Huang J, Chen L, Wang R (2024) miR-151a-3p regulates the TNIK\/PI3K\/Akt axis and influences the progression of polycystic ovary syndrome. J Matern Fetal Neonatal Med 37:2372695. https:\/\/doi.org\/10.1080\/14767058.2024.2372695","journal-title":"J Matern Fetal Neonatal Med"},{"key":"2648_CR38","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1007\/s12035-021-02714-1","volume":"59","author":"Z Zhou","year":"2022","unstructured":"Zhou Z, Tu Z, Zhang J, Tan C, Shen X, Wan B, Li Y, Wang A, Zhao L, Hu J, Ma N, Zhou J, Chen L, Song Y, Lu W (2022) Follicular Fluid-Derived Exosomal MicroRNA-18b-5p regulates PTEN-Mediated PI3K\/Akt\/mTOR signaling pathway to inhibit polycystic ovary syndrome development. Mol Neurobiol 59:2520\u20132531. https:\/\/doi.org\/10.1007\/s12035-021-02714-1","journal-title":"Mol Neurobiol"},{"key":"2648_CR39","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1186\/s12905-022-01994-6","volume":"22","author":"X Yang","year":"2022","unstructured":"Yang X, Wang K, Lang J, Guo D, Gao H, Qiu Y, Jin X, Zhang M, Shi J, Ma Q, Ma Q, Wen Z (2022) Up-regulation of miR-133a-3p promotes ovary insulin resistance on granulosa cells of obese PCOS patients via inhibiting PI3K\/AKT signaling. BMC Womens Health 22:412. https:\/\/doi.org\/10.1186\/s12905-022-01994-6","journal-title":"BMC Womens Health"},{"key":"2648_CR40","doi-asserted-by":"publisher","first-page":"2784","DOI":"10.1016\/j.stemcr.2021.10.001","volume":"16","author":"H Lawson","year":"2021","unstructured":"Lawson H, van de Lagemaat LN, Barile M, Tavosanis A, Durko J, Villacreces A, Bellani A, Mapperley C, Georges E, Martins-Costa C, Sepulveda C, Allen L, Campos J, Campbell KJ, O\u2019Carroll D, Gottgens B, Cory S, Rodrigues NP, Guitart AV, Kranc KR (2021) CITED2 coordinates key hematopoietic regulatory pathways to maintain the HSC pool in both steady-state hematopoiesis and transplantation. Stem Cell Rep 16:2784\u20132797. https:\/\/doi.org\/10.1016\/j.stemcr.2021.10.001","journal-title":"Stem Cell Rep"},{"key":"2648_CR41","doi-asserted-by":"publisher","first-page":"9485","DOI":"10.2147\/JIR.S486596","volume":"17","author":"R Deng","year":"2024","unstructured":"Deng R, Yang H, Zhong W, Zhou J, Huang G, Zeng K (2024) CITED2 mediates metabolic reprogramming in renal tubular epithelial cells via the AKT signaling pathway to induce Sepsis-Associated acute kidney injury. J Inflamm Res 17:9485\u20139505. https:\/\/doi.org\/10.2147\/JIR.S486596","journal-title":"J Inflamm Res"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-025-02648-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-025-02648-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-025-02648-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T13:42:41Z","timestamp":1760362961000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-025-02648-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,26]]},"references-count":41,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["2648"],"URL":"https:\/\/doi.org\/10.1007\/s40618-025-02648-8","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,26]]},"assertion":[{"value":"26 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"There is no conflict of interest in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}